Eastern Europe and Baltic Course I: Immunotherapy in Lung Cancer by IASLC will be held at December 30, 2024.
This Exclusive Virtual Course focuses on the latest updates in lung cancer treatment in Eastern Europe and the Balkan States, with a particular emphasis on immunotherapy. In Series I, leading thoracic oncology experts from the region will discuss how immunotherapy is revolutionizing lung cancer care. Key topics include the integration of biomarkers for immunotherapy, effective management strategies for advanced disease, and addressing challenges such as pneumonitis. Participants will gain valuable insights into the evolving landscape of lung cancer treatment, particularly in Eastern Europe and the Balkans, and learn how immunotherapy is improving patient outcomes in these regions.
See the Speakers of the Course Below:
